PeptideStack is an independent peptide research resource with product pages, supplier comparisons, discount-code resources, research guides, and calculator tools for laboratory research audiences
Thamarai Kannan, H., Umapathy, S., & Pan, I
ASPEN is a multinational, randomized, double-blind, placebo-controlled, parallel-group study that is evaluating the frequency and severity of exacerbations as well as the safety and tolerability of long-term (52-week) treatment with brensocatib compared with placebo in patients with non-cystic fibrosis bronchiectasis
Indeed, one of the poorly discussed limits of cystine transport study in vitro is the fact that the commonly used culture media contains exclusively oxidized form of cysteine